Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 800 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe EMA Recommends Extension of Therapeutic Indications for Ponatinib MOST POPULAR NHL Player Carey Price Surprises 11-Year-Old Boy Who Just Lost Mom... June 24, 2019 Intracranial Efficacy of Pembrolizumab in Patients with Brain Metastases June 20, 2023 Significant Intracranial Efficacy and Survival Benefits of Osimertinib in Patients with... July 25, 2024 EMA Recommends Granting a Marketing Authorisation for Elinzanetant September 26, 2025 Load more HOT NEWS GreaterGood Is Donating Thousands of Masks to Help Animal Shelters Stay... Breast Cancer Patient Devotes Her Time to Driving Others to Treatment FDA Approves Pembrolizumab with Chemotherapy for Primary Advanced or Recurrent Endometrial... Nirogacestat Shows Significant Benefit in Patients with Progressing Desmoid Tumours
